key: cord-0739455-2rr20yas authors: Lee, Jonghoo; Song, Jae-Uk; Shim, Sung Ryul title: Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis date: 2021-09-16 journal: J Clin Virol DOI: 10.1016/j.jcv.2021.104985 sha: da0c587ccae61aa14b4790c8738e5e28a881a0ba doc_id: 739455 cord_uid: 2rr20yas BACKGROUND: Timely and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is crucial to reduce the risk of viral transmission. We investigated the diagnostic accuracy of rapid antigen detection tests (RADTs) in the diagnosis of SARS-CoV-2 infection. METHODS: A systematic literature search was performed using Pubmed, Embase, and the Cochrane Central Register. The sensitivity, specificity, diagnostic odds ratio (DOR), and a hierarchical summary receiver-operating characteristic curve (HSROC) of RADTs were pooled using meta-analysis. We used commercial and laboratory-developed reverse transcriptase-polymerase chain reaction (RT-PCR) as reference standards. RESULTS: We identified 24 studies comprising 14,188 patients. The overall pooled sensitivity, specificity, and DOR of RADTs for diagnosis of SARS-CoV-2 were 0.68 (95%CI, 0.59 to 0.76), 0.99 (95%CI, 0.99 to 1.00), and 426.70 (95% CI, 168.37 to 1081.65), respectively. RADTs and RT-PCR had moderate agreement with an estimated pooled Cohen's kappa statistic of 0.75 (95%CI, 0.74-0.77), and area under the HSROC of 0.98 (95%CI, 0.96 to 0.99). The pooled sensitivity of RADTs was significantly increased in subjects with viral load of Ct-value ≤25 or in those within 5 days after symptom onset than it was in subjects with lower viral loads or longer symptom duration. CONCLUSIONS: The overall sensitivity of RADTs was inferior to that of the RT-PCR assay. The RADTs were more sensitive for samples of Ct-value ≤25 and might be suitable for subjects in the community within 5 days of symptom onset. Coronavirus disease 2019 (COVID- 19) , which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused global health concerns since December 2019 [1, 2] . The rapid and accurate diagnosis of SARS-CoV-2 infection is very important to reduce the spread of the virus through patient management and isolation [3] . The current standard for detection of SARS-CoV-2 is viral RNA amplification testing such as reverse transcriptase-polymerase chain reaction (RT-PCR) [4] . Meanwhile, the COVID-19 pandemic has increased the demand for rapid, accurate, and convenient detection tests. The World Health Organization (WHO) and several countries have released guidelines for the use of rapid antigen detection tests (RADTs) [5] [6] [7] . These tests can be performed without a trained expert or specialized instrument and interpreted within 30 min In this study, our objective was to evaluate the diagnostic accuracy of RADTs in the diagnosis of SARS-CoV-2 infection from respiratory tract specimens. We performed a systematic review and meta-analysis of diagnostic accuracy studies. This meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses of Diagnostic Test Accuracy Studies statement [10]. We performed a comprehensive search of three electronic databases (Pubmed, Embase, and the Cochrane Central Register) through December 2020. The search terms included the following: ((("2019 nCoV" OR "2019nCoV" OR "2019 novel coronavirus" OR " COVID 19" OR "COVID19" OR "new coronavirus" OR "novel coronavirus" OR "novel corona virus" OR "SARS-CoV-2") OR (("Wuhan" AND ("coronavirus" OR "corona virus")) OR "severe acute respiratory syndrome coronavirus 2"))) AND (("rapid test*" OR "quick test*" OR "point-of-care") OR "antigen" OR ("STANDARD Q" OR "PANBIO") OR "COVID-19 testing"[MeSH terms]). Since this study was a systematic review of published articles, neither informed consent nor ethics approval was required. We also performed a manual search of the references listed in relevant review articles. We included studies that met the following inclusion criteria: (1) full-length reports published in peer-reviewed English language journals; (2) evaluated the performance of the RADTs for diagnosis of SARS-CoV-2 infection using respiratory samples compared to the reference standard; (3) included patients with suspected SARS-CoV-2 infection; and (4) provided sufficient data to calculate absolute numbers of true-positive, false-positive, false-negative, and true-negative results. Articles were excluded if they were review articles, case reports, commentaries, or studies reporting outcomes without raw data or peer review. The participant demographics and underlying diseases were not restricted. The reference standard was either commercial or laboratory-developed RT-PCR. Positive results for RT-PCR were defined as a cycle threshold (Ct)-value <40 for target genes, including the envelope gene (E) of Sarbecovirus, RNA-dependent RNA polymerase (RdRp), and nucleocapsid (N) genes of SARS-CoV-2. We allowed the following respiratory specimens: bronchoalveolar lavage, nasopharyngeal, nasal, oropharyngeal, and throat samples. Two authors independently extracted all potentially relevant studies and reviewed each study according to the predefined eligibility criteria. After this review, the data were extracted. Any disagreements between the two authors during study selection or data extraction were resolved by discussion. A predefined form was used to extract the following data from each study: author, place of study, number of samples, the index test, comparison test, and specimen type(s). As recommended by the Cochrane Collaboration, we used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool to assess the risk of bias in diagnostic test accuracy [11] . The studies were said to have a "low" risk of bias if the risk assessment was scored as "low" in the following four domains: patient selection, index test, reference standard, and flow and timing. If any domain was assessed to have a "high" risk of bias, or if two or more domains were considered as "unclear," then the study was classified at having a "high" risk of bias. If a study was assessed as being "unclear" in one of the four domains, the risk of bias was ranked as "unclear." Any discrepancies between the two authors were resolved by consensus. For the diagnostic meta-analysis, we used the bivariate random-effects model to generate pooled estimates with 95% confidence intervals (CIs). We extracted the numbers of patients with true-positive, false-positive, false-negative, and true negative test results either directly or through a recalculation (based on the reported measures of accuracy and the prevalence and sample size of the included study). The pooled sensitivity and specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), Cohen's kappa (κ), and area under the receiver-operating characteristic curve (AUC) were calculated by combining each study's results [12] . We also constructed hierarchical summary receiver-operating characteristic curves (HSROCs). The literature search process is shown in Figure 1 . We initially identified 536 articles from Pubmed, 1,871 articles from EMBASE, 198 articles from the Cochrane library, and two additional articles from hand-searching. After removing duplicate articles, we screened 2,282 potentially eligible articles. After reviewing the title and abstracts, 2,238 search records were removed. The remaining 46 articles were eligible for reading the full text. Twenty-two articles were excluded for the reasons shown in Figure 1 . After qualitative and quantitative syntheses, 24 studies were included in our final analysis . Table 1 summarizes the features of the included studies. Twenty-four studies involving 14,188 subjects met the defined inclusion criteria. The number of patients in each trial ranged from 19 to 3,410. For QUADAS assessment, we only judged one study to be at low risk of bias. In contrast, the risk of bias in most studies was unclear or high because of insufficient reporting. We also had concerns about the applicability of the results across the studies included in the analysis. Table 2 summarizes the results of subgroup analyses for the pooled sensitivity of the included studies. We first investigated the relationship between the SARS-CoV-2 viral load (as Ct values determined by viral RNA amplification tests) and the positive results of RADTs. We extracted sensitivity data associated with viral loads from 16 studies of RADTs [15, 16, 18, 21, 23-31, 33, 34, 37] . In 15 evaluations of the 13 studies, we extracted data according to Ct-values ≤25 and >25 [15, 18, 21, 23-28, 31, 33, 34, 37] . Data extracted from the 12 studies of Ct-values ≤30 and >30 were evaluated [15, 16, 18, 21, 23-26, 29, 30, 33, 34] . Nine studies included all data for Ct-values ≤25, >25, ≤30, and >30 [15, 18, 21, 23-26, 33, 34] . The pooled sensitivity of the RADTs in patients with COVID-19 symptoms tended to be higher than in those without symptoms, although there were no significant differences (0.72; 95%CI, 0.57 to 0.83 and 0.52; 95%CI, 0.36 to 0.67, respectively; P = 0.220). There were substantial differences in pooled sensitivity between symptom duration ≤5 days and > 5 days (0.87; 95%CI, 0.82 to 0.91 and 0.73; 95%CI, 0.62 to 0.82, respectively; P = 0.003). Adults had a significant association with an increased rate of pooled sensitivity compared to children (0.86; 95%CI, 0.82 to 0.90 and 0.52; 95%CI, 0.41 to 0.63, respectively; P <0.001). In this study, we compared the diagnostic accuracy of RADTs with that of RT-PCR for the diagnosis of SARS-CoV-2 using a systemic review and meta-analysis approach. We found that RADTs and RT-PCR had moderate agreement (estimated pooled Cohen's kappa statistic of 0.75). The RADTs had overall low sensitivity of 0.68 compared to RT-PCR. The pooled sensitivity further declined to 0.30 when the Ct-value was > 30, indicating that the RADTs have high rates of false negative results when the subjects have low viral load. The WHO currently recommends RADTs that meet the minimum performance requirements of ≥80% sensitivity and ≥97% specificity compared with that of molecular testing, while the European Centre for Disease Prevention and Control suggests the use of tests with performance closer to RT-PCR, i.e., ≥90% sensitivity and ≥97% specificity [7, 39] . However, because the findings of our study showed lower overall sensitivity of RADTs than that recommended by the WHO and the ECDPC, the usefulness of RADTs as a replacement for molecular testing seemed to be limited. We included several types of RADTs whose sensitivity varied largely across studies (from 0% to 98%). This method might have caused heterogeneity in the diagnostic availability of the overall RADTs. Recently, the WHO announced an emergency use listing for in vitro diagnostics to detect SARS-CoV-2 [13]. Two RADTs, the Panbio COVID-19 Ag rapid test device and Standard Q COVID-19 Ag test, were included in the WHO statements [13] . We found that the pooled sensitivity of the Standard Q COVID-19 Ag test was relatively higher than that of the overall RADTs. In contrast, the diagnostic performances of the Panbio COVID-19 Ag rapid test device were similar to that of overall RADTs. However, because of data limitations, we could not investigate the differences of baseline characteristics among the groups. Therefore, we could not conclude the superiority of specified commercial RADTs. Large heterogeneities generally are reported in systematic reviews of studies on diagnostic test accuracy, and one purpose of our study was to examine the evidence of heterogeneity among studies [40] . We tried to explain the heterogeneity using subgroup analysis. There are several possible sources of this heterogeneity. First, the low overall sensitivity of RADTs might be caused by differences in the diagnostic availability of tests related to viral load. RADTs have been used to identify other viruses such as influenza virus and respiratory syncytial virus [41, 42] . However, previous studies have found that RADTs had relative low sensitivity in the diagnosis of other viruses and were influenced by factors related to viral load [41, 42] . Similarly, in samples with a Ct-value ≤25 or ≤30, the pooled sensitivities of the tests were 0.94 and 0.84, respectively. In contrast, the pooled sensitivities of RADTs in samples with Ct >25 or Ct >30 were 0.38 and 0.30, respectively. Second, the presence of symptoms was considered a possible factor of heterogeneity. There have been conflicting data on the association between the presence of symptoms and Ct-values [43] [44] [45] . While some reports have suggested that asymptomatic patients with SARS-CoV-2 infection have a lower viral load than do symptomatic patients, others showed similar viral load between asymptomatic and symptomatic patients [43] [44] [45] . This discrepancy indicates the possibility of infectivity in asymptomatic or pre-symptomatic patients [44] . Our findings revealed that asymptomatic patients tended to show relatively low sensitivity of 0.52 in the detection of SARS-CoV-2. Third, the duration of symptoms after onset was considered another factor in study heterogeneity. The RNA concentrations of viral load peak within 5 days of the onset of symptoms [46] . A recent systematic review also suggested that that the viral load of SARS-CoV-2 from upper respiratory tract specimens peaked around the time of symptom onset or a few days after [47] . In our pooled analysis of patients with duration of symptoms within 5 days, the sensitivity of RADTs increased to 0.87. In contrast, these tests might not be useful in asymptomatic patients based on a low sensitivity of 0.52. On the basis of our findings, we suggest that RADTs will provide satisfactory sensitivity in community subjects with early onset of symptoms during the pandemic period. However, we believe that the performance of rapid molecular tests is more reasonable in specific situations that require precise test results, such as emergency pre-operative/-interventional screening, inpatient admission for other diseases, or identification of symptomatic medical workers [48] . Fourth, the pooled sensitivity of RADTs in the diagnosis of SARS-CoV-2 was lower in children than it was in adults in this study. Previous studies comparing the RNA load of SARS-CoV-2 RNA across age groups have reported inconsistent results [49] . Meanwhile, recent epidemiological data revealed that children have a lower susceptibility to the virus than do adults. Children also do not seem to be major sources of viral transmission [49, 50] . We considered the possibility that the studies included in our analysis had a high proportion of children with low viral load. This might lead to lower overall sensitivity in the present study. Finally, the impact of training for testing can be an issue. Previous studies have reported that the diagnostic accuracy of the RADTs was lower when performed by an untrained individual or in a home setting compared with healthcare professionals [51, 52] . We could not investigate the performances of the RADTs related to this factor due to the limited data. Considering the overall low sensitivity of RADTs, future research should focus on the development of novel RADTs and the strategies for their performances. For example, lateral flow devices are a new form of testing that detect SARS-CoV-2 viral antigens by immunoassays [51] . The UK COVID-19 Lateral Flow Oversight group suggested that lateral flow devices had promising performance characteristics for mass population testing [51] . Various strategies are required to improve the sensitivity of RADTs, such as serial sampling, digital results, and enhanced training [51] . This study has some limitations. First, the studies included in our analysis had low methodological quality and significant risk of publication bias. Therefore, our results should be interpreted carefully. Second, we used various types of RADTs and RT-PCR assays. We also handled multiple kinds of repository samples without distinction. These factors might have introduced bias. Third, even though RT-PCR tests are regarded as the standard for detecting SARS-CoV-2, their sensitivity can be characterized poorly due to the lack of an international standard or difficulties in appropriate timing of testing in asymptomatic subjects for optimal sensitivity [53] . Especially, a recent pooled analysis revealed that the possibility of false negative results for RT-PCR increased in the early course of infection [54] . Depending on the low sensitivity of RT-PCR, the sensitivity of RADTs should be considered together. We demonstrated that RADTs have good specificity in the diagnosis of SARS-CoV-2 in respiratory samples but low sensitivity (of 0.68) compared to those of RT-PCR. Therefore, when RADTs produce negative results, they should be coupled to confirmatory tests in situations that require accurate test results. The test was more sensitive in patients with viral load of Ct-value ≤25 and might be useful for patients within 5 days of symptoms onset (when the viral load in the upper respiratory tract is at its peak). Considering that RADTs are individual use tests that are rapid and easy to use, they can be used carefully in community patients with early onset of symptoms. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. Clinical Characteristics of 138 Hospitalized Patients With SARS-CoV-2 is an appropriate name for the new coronavirus Effect of delay in diagnosis on transmission of COVID-19 Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR World Health Organization, Coronavirus disease (COVID-19) Pandemic -Emergency The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study Field evaluation of a rapid antigen test (Panbio COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres Comparison of Quidel Sofia SARS FIA Test to Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection Evaluation of the Panbio Covid-19 rapid antigen detection test device for the screening of patients with Covid-19 Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients. International journal of infectious diseases Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context Field Evaluation of the Performance of a SARS-CoV-2 Antigen Rapid Diagnostic Test in Uganda using Nasopharyngeal Samples Field performance and public health response using the BinaxNOW TM Rapid SARS-CoV-2 antigen detection assay during community-based testing Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis Performance of a Point-of-Care Test for the Rapid Detection of SARS Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread? Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Pointof-Care Test World Health Organization (WHO) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis Diagnostic performance of influenza viruses and RSV rapid antigen detection tests in children in tertiary care Viral dynamics in asymptomatic patients with COVID-19 SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19 Virological assessment of hospitalized patients with COVID-2019 SARS-CoV-2 detection, viral load and infectivity over the course of an infection Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19 Age-dependent effects in the transmission and control of COVID-19 epidemics Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.